{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T09:33:23Z","timestamp":1786700003361,"version":"build-2736575974"},"reference-count":24,"publisher":"MDPI AG","issue":"8","license":[{"start":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T00:00:00Z","timestamp":1786665600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Medicina"],"abstract":"<jats:p>Background and Objectives: Oxidative stress and nitric oxide (NO)-related inflammatory activity contribute to chronic obstructive pulmonary disease (COPD), particularly during acute exacerbation of COPD (AECOPD). Myeloperoxidase (MPO) reflects neutrophil-related oxidative activity, whereas NO is involved in airway inflammation, endothelial regulation, and systemic inflammatory responses. This study compared serum MPO and NO levels among patients with AECOPD, patients with stable COPD, and healthy controls, and explored their discriminatory performance for distinguishing AECOPD from stable COPD. Materials and Methods: This cross-sectional comparative observational study prospectively enrolled 90 participants: 30 patients with AECOPD, 30 patients with stable COPD, and 30 healthy adult controls. COPD was confirmed by post-bronchodilator spirometry. Serum MPO and NO levels were measured using commercially available enzyme-linked immunosorbent assay kits. Group comparisons, exploratory subgroup analyses, correlation analyses, regression models, and receiver operating characteristic (ROC) curve analyses were performed. Results: Serum NO and MPO levels increased stepwise from healthy controls to stable COPD and AECOPD. Median serum NO levels were 109.79, 170.05, and 227.95 \u00b5mol\/L, respectively, and median serum MPO levels were 4.14, 8.00, and 9.98 ng\/mL, respectively (both p &lt; 0.001). GOLD stage 3\u20134 disease was associated with higher levels of both biomarkers than GOLD stage 1\u20132 disease (both p &lt; 0.001). In COPD-only exploratory logistic regression, serum NO and MPO were associated with AECOPD status. ROC analysis showed AUC values of 0.911 for serum NO and 0.811 for serum MPO, with no significant AUC difference by DeLong\u2019s test (p = 0.187). Conclusions: Serum MPO and NO levels were progressively higher across healthy control, stable COPD, and AECOPD states. These exploratory findings suggest that systemic oxidative and NO-associated inflammatory activity may reflect COPD clinical state; however, sample-specific ROC cut-offs require external validation before diagnostic use.<\/jats:p>","DOI":"10.3390\/medicina62081558","type":"journal-article","created":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T08:08:29Z","timestamp":1786694909000},"page":"1558","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Serum Myeloperoxidase and Nitric Oxide Levels in Acute Exacerbation and Stable COPD Compared with Healthy Controls: A Cross-Sectional Exploratory Biomarker Study"],"prefix":"10.3390","volume":"62","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6898-8911","authenticated-orcid":false,"given":"G\u00fcl\u015fah","family":"Ethemo\u011flu","sequence":"first","affiliation":[{"name":"Department of Chest Diseases, Faculty of Medicine, Harran University, \u015eanl\u0131urfa 63200, T\u00fcrkiye"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5745-9678","authenticated-orcid":false,"given":"Nihayet","family":"Bayraktar","sequence":"additional","affiliation":[{"name":"Department of Biochemistry, Faculty of Medicine, Harran University, \u015eanl\u0131urfa 63200, T\u00fcrkiye"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5025-2367","authenticated-orcid":false,"given":"Hamza","family":"Erdo\u011fdu","sequence":"additional","affiliation":[{"name":"Department of Biostatistics, Faculty of Medicine, Harran University, \u015eanl\u0131urfa 63200, T\u00fcrkiye"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-8337-8361","authenticated-orcid":false,"given":"Hatice","family":"Kalayc\u0131o\u011flu Avan","sequence":"additional","affiliation":[{"name":"Department of Chest Diseases, Faculty of Medicine, Harran University, \u015eanl\u0131urfa 63200, T\u00fcrkiye"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,8,14]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1164\/rccm.202301-0106PP","article-title":"Global Initiative for Chronic Obstructive Lung Disease 2023 Report: GOLD Executive Summary","volume":"207","author":"Celli","year":"2023","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1016\/S2213-2600(21)00555-5","article-title":"Pathogenesis of chronic obstructive pulmonary disease: Understanding the contributions of gene\u2013environment interactions across the lifespan","volume":"10","author":"DeMeo","year":"2022","journal-title":"Lancet Respir. Med."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1056\/NEJMoa0909883","article-title":"Susceptibility to Exacerbation in Chronic Obstructive Pulmonary Disease","volume":"363","author":"Hurst","year":"2010","journal-title":"N. Engl. J. Med."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1136\/thorax.57.10.847","article-title":"Relationship between Exacerbation Frequency and Lung Function Decline in Chronic Obstructive Pulmonary Disease","volume":"57","author":"Donaldson","year":"2002","journal-title":"Thorax"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1183\/09031936.00092506","article-title":"Inflammatory Changes, Recovery and Recurrence at COPD Exacerbation","volume":"29","author":"Perera","year":"2007","journal-title":"Eur. Respir. J."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"2353","DOI":"10.1001\/jama.2013.5732","article-title":"Inflammatory Biomarkers and Exacerbations in Chronic Obstructive Pulmonary Disease","volume":"309","author":"Thomsen","year":"2013","journal-title":"JAMA"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1164\/rccm.201110-1792OC","article-title":"Inflammatory Biomarkers Improve Clinical Prediction of Mortality in Chronic Obstructive Pulmonary Disease","volume":"185","author":"Celli","year":"2012","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1164\/rccm.201104-0597OC","article-title":"Acute Exacerbations of Chronic Obstructive Pulmonary Disease: Identification of Biological Clusters and Their Biomarkers","volume":"184","author":"Bafadhel","year":"2011","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1136\/thx.2004.027946","article-title":"Oxidative Stress and Airway Inflammation in Severe Exacerbations of COPD","volume":"60","author":"Drost","year":"2005","journal-title":"Thorax"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1164\/rccm.200506-859OC","article-title":"Infections and Airway Inflammation in Chronic Obstructive Pulmonary Disease Severe Exacerbations","volume":"173","author":"Papi","year":"2006","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1378\/chest.14-2637","article-title":"Oxidative and Nitrosative Stress and Histone Deacetylase-2 Activity in Exacerbations of COPD","volume":"149","author":"Footitt","year":"2016","journal-title":"Chest"},{"key":"ref_12","doi-asserted-by":"crossref","unstructured":"Zinellu, E., Zinellu, A., Fois, A.G., Fois, S.S., Piras, B., Carru, C., and Pirina, P. (2021). Oxidative Stress Biomarkers in Chronic Obstructive Pulmonary Disease Exacerbations: A Systematic Review. Antioxidants, 10.","DOI":"10.3390\/antiox10050710"},{"key":"ref_13","doi-asserted-by":"crossref","unstructured":"Taniguchi, A., Tsuge, M., Miyahara, N., and Tsukahara, H. (2021). Reactive Oxygen Species and Antioxidative Defense in Chronic Obstructive Pulmonary Disease. Antioxidants, 10.","DOI":"10.3390\/antiox10101537"},{"key":"ref_14","doi-asserted-by":"crossref","unstructured":"Barnes, P.J. (2022). Oxidative Stress in Chronic Obstructive Pulmonary Disease. Antioxidants, 11.","DOI":"10.3390\/antiox11050965"},{"key":"ref_15","doi-asserted-by":"crossref","unstructured":"Kume, H., Yamada, R., Sato, Y., and Togawa, R. (2023). Airway Smooth Muscle Regulated by Oxidative Stress in COPD. Antioxidants, 12.","DOI":"10.3390\/antiox12010142"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1111\/cmi.12312","article-title":"Myeloperoxidase in Human Neutrophil Host Defence","volume":"16","author":"Nauseef","year":"2014","journal-title":"Cell. Microbiol."},{"key":"ref_17","doi-asserted-by":"crossref","unstructured":"Park, H.Y., Man, S.F.P., Tashkin, D., Wise, R.A., Connett, J.E., Anthonisen, N.A., and Sin, D.D. (2013). The Relation of Serum Myeloperoxidase to Disease Progression and Mortality in Patients with Chronic Obstructive Pulmonary Disease. PLoS ONE, 8.","DOI":"10.1371\/journal.pone.0061315"},{"key":"ref_18","unstructured":"Global Initiative for Chronic Obstructive Lung Disease (GOLD) (2025). Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease: 2025 Report, Global Initiative for Chronic Obstructive Lung Disease. Available online: https:\/\/goldcopd.org\/2025-gold-report\/."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"3167","DOI":"10.21105\/joss.03167","article-title":"Visualizations with statistical details: The \u2018ggstatsplot\u2019 approach","volume":"6","author":"Patil","year":"2021","journal-title":"J. Open Source Softw."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1152\/physrev.00034.2003","article-title":"Nitric Oxide in Health and Disease of the Respiratory System","volume":"84","author":"Ricciardolo","year":"2004","journal-title":"Physiol. Rev."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1164\/rccm.200904-0493OC","article-title":"Nitric Oxide Synthase Isoenzyme Expression and Activity in Peripheral Lung Tissue of Patients with Chronic Obstructive Pulmonary Disease","volume":"181","author":"Brindicci","year":"2010","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1186\/s12931-019-1133-8","article-title":"Dysregulation of the Endothelial Nitric Oxide Pathway Is Associated with Airway Inflammation in COPD","volume":"20","author":"Csoma","year":"2019","journal-title":"Respir. Res."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"h5527","DOI":"10.1136\/bmj.h5527","article-title":"STARD 2015: An Updated List of Essential Items for Reporting Diagnostic Accuracy Studies","volume":"351","author":"Bossuyt","year":"2015","journal-title":"BMJ"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"120799","DOI":"10.1016\/j.cca.2025.120799","article-title":"Myeloperoxidase as a Biomarker in COPD","volume":"582","author":"Rekha","year":"2025","journal-title":"Clin. Chim. Acta"}],"container-title":["Medicina"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1648-9144\/62\/8\/1558\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T08:54:36Z","timestamp":1786697676000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1648-9144\/62\/8\/1558"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,14]]},"references-count":24,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2026,8]]}},"alternative-id":["medicina62081558"],"URL":"https:\/\/doi.org\/10.3390\/medicina62081558","relation":{},"ISSN":["1648-9144"],"issn-type":[{"value":"1648-9144","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,14]]}}}